| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman And CEO | Chief Executive Officer
1 company
Trieu Vuong is a Chairman And CEO at Oncotelic Therapeutics, Inc.. Recent SEC Form 4 filings include 16 buys and 0 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 335,759 | $0.04 | $15,013.25 | +0.2% | |
| Jul 10, 2025 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 198,737 | $0.01 | $993.69 | - | |
| Jan 31, 2025 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 346,844 | $0.03 | $9,711.63 | +0.1% | |
| Nov 22, 2024 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 298,499 | $0.03 | $8,626.62 | +0.3% | |
| Aug 23, 2024 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 500,000 | $0.02 | $10,000.00 | +0.5% | |
| Jun 29, 2023 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 500,000 | $0.02 | $10,875.00 | +0.3% | |
| Jun 16, 2023 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 100,000 | $0.03 | $2,600.00 | +0.1% | |
| Jun 14, 2023 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 400,000 | $0.03 | $13,040.00 | +0.4% | |
| May 26, 2023 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 126,888 | $0.03 | $4,326.88 | +0.1% | |
| May 2, 2023 | OTLC Oncotelic Therapeutics, Inc. | Chairman And CEO | Buy | 100,000 | $0.05 | $4,500.00 | +0.1% |